|
 Expeditors International of Washington Inc. reported Tuesday second-quarter profit and revenue that rose well above expectations, and said logistics challenges are likely to remain through the rest of the year while demand is expected to remain robust. The airfreight and ocean freight company's stock was still inactive in premarket trading. Net income rose to $316.4 million, or $1.84 a share, from $183.9 million, or $1.09 a share, in the year-ago period. The FactSet consensus for earnings per share was $1.63. Revenue increased 49.7% to $3.61 billion, above the FactSet consensus of $3.40 billion. Cost of transportation and other expenses rose 56% to $2.60 billion. "Robust demand is bumping up against capacity constraints in the air and ocean markets, all of which is made more challenging by limited warehouse space, staffing constraints, port congestion, equipment dislocations, and driver shortages, not to mention additional disturbances such as the closure of the Yantian port due to a COVID-19 outbreak in May or the blockage of the Suez Canal back in March," said Chief Executive Jeffrey Musser. "While we remain optimistic that conditions will improve over time, we are unable to predict when that might take place, or how even the recovery might be, and we believe that demand will likely continue to outstrip capacity in both air and ocean for the near term, keeping buy/sell rates unsettled for at least the duration of 2021." The stock has rallied 12.0% over the past three months, while the Dow Jones Transportation Average has dropped 8.0% and the Dow Jones Industrial Average has gained 2.1%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
RELATED ARTICLES | | |
|
Bausch Health Companies Inc. shares fell 6% in premarket trade Tuesday, after the company posted a surprise loss in the second quarter, hurt by higher costs stemming from litigation, selling, general and administration expenses and the impact of a recall caused by a quality issue at a third-party supplier. The loss came to $595 million, or $1.66 a share, wider than the loss of $326 million, or 92 cents a share, posted in the year-earlier period. Revenue rose to $2.100 billion rom $1.664 billion. The FactSet consensus was for EPS of 95 cents and revenue of $2.118 billion. The company, the former Valeant, lowered its full-year guidance and now expects revenue of $8.40 billion to $8.60 billion, down from earlier guidance of $8.60 billion to $8.80 billion. The FactSet consensus is for $8.60 billion. It made several other announcements with earnings, including that Thomas J. Appio will become CEO of Bausch Pharma as soon as the separation of the Bausch & Lomb eye health care business has been completed. The company will seek an initial public offering of its Solta Medical business, a provider in medical aesthetics. Shares have gained 43% in the year to date, while the S&P 500 has gained 16.8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
The global tally for the coronavirus-borne illness headed above 198.9 million on Tuesday, while the death toll climbed above 4.23 million according to data aggregated by Johns Hopkins University. The U.S. leads the world with a total of 35.1 million cases and in deaths with 613,679 as the highly infectious delta variant continues to spread fast, especially in states with low vaccination rates. The Centers for Disease Control and Prevention said Monday the delta variant is "highly contagious" and urged unvaccinated people to get their shots and for employers to require vaccination. "The delta variant is highly contagious," CDC director Dr. Rochelle Walensky said during the briefing. "To put this in perspective: if you get sick with the alpha variant, you could infect about two other unvaccinated people. If you get sick with the delta variant, we estimate that you can infect about five other unvaccinated people - more than twice as many as the original strain."
India is second by cases at 31.7 million and third by deaths at 425,195 according to its official numbers, which are expected to be undercounted.
Brazil is second in deaths at 557,223, but is third in cases at 19.9 million. Mexico has fourth-highest death toll at 241,279 but has recorded just 2.9 million cases, according to its official numbers. In Europe, Russia continues to pull ahead of the U.K. by deaths at 158,263, while the U.K. has 130,039, making Russia the country with the fifth-highest death toll in the world and highest in Europe.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Wolverine World Wide Inc. announced Tuesday that it has acquired British lifestyle brand Sweaty Betty in a $410 million all-cash deal. Wolverine funded the transaction with cash and credit. Founded in 1998, more than 80% of Sweaty Betty's sales come through direct-to-consumer channels. "The acquisition of Sweaty Betty complements our strategic shift over the last several years from a traditional footwear wholesaler into a consumer-obsessed, digital-focused growth company," said Wolverine Chief Executive Blake Krueger in a statement. Wolverine brands include the namesake label, Keds, Saucony and Merrell. "It also gives us a leadership position in the growing women's activewear category," he said. Wolverine expects the deal to be earnings accretive in a year. Wolverine acquired all of the shares of Lady of Leisure InvestCo Limited, the group that owns Sweaty Betty, from L Catterton and other shareholders. Wolverine stock rose 1.3% in premarket trading after the deal, and has gained 7.7% for the year to date. The S&P 500 index is up 16.8% for 2021 so far.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Shares of Arconic Corp. slipped 0.2% in premarket trading Tuesday, after the aluminum company swung to a loss, which included a one-time pension charge, and revenue that came up a bit shy of forecasts. The net loss was $427 million, or $3.89 a share, after net income of $52 million, or 48 cents a share, in the year-ago period. The results included a pension settlement charge of $423 million related to the partial annuitization of U.S. pension obligations. Sales increased 51.7% to $1.80 billion, but was below the FactSet consensus of $1.87 billion, as rolled products revenue grew 67.5% to $1.47 billion. Arconic raised its 2021 revenue guidance range to $7.3 billion to $7.6 billion from $7.1 billion to $7.4 billion. The company said after buying back nearly $9 million worth of stock in the second quarter, it repurchased more than doubled that amount during July. The stock has run up 18.9% year to date through Monday, while the S&P 500 has gained 16.8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Shares of DuPont de Nemours Inc. rallied 1.7% in premarket trading Tuesday after the specialty materials and chemicals company reported second-quarter earnings that beat expectations, amid an ongoing recovery in markets hurt by the COVID-19 pandemic a year ago, and raised its full-year outlook. The company swung to net income of $478 million, or 90 cents a share, from a loss of $2.48 billion, or $3.37 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share rose to $1.06 from 31 cents, beating the FactSet consensus of 94 cents. Sales grew 25.7% to $4.14 billion, above the FactSet consensus of $3.99 billion. For 2021, the company raised its adjusted EPS guidance range to $4.24 to $4.30 from $3.60 to $3.75 and listed its sales guidance to $16.45 billion to $16.55 billion from $15.7 billion to $15.9 billion. "Continued positive momentum in almost all of our key end-markets, including semiconductor, smartphones, automotive, and residential construction, enabled us to deliver strong second quarter results ahead of expectations with year-over-year and sequential growth in all three reporting segments," said Chief Executive Ed Breen. The stock has gained 5.0% year to date through Monday, while the S&P 500 has gained 16.8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Tyson Foods Inc. announced Tuesday that it will require all office staff to be vaccinated by October 1, and all other workers to be vaccinated by November 1, pending discussions with locations represented by unions. Tyson said nearly half of its workers are already vaccinated, and the company has hosted more than 100 vaccination events. The meat manufacturer says it will provide $200 to workers, subject to those union discussions, along with the policy to compensate workers for up to four hours of pay if they're vaccinated outside of their shift or through an external source. Tyson has spent $700 million to date on protective gear, vaccinations and other COVID-19-related measures. At one point, the illness had infected 1,000 of 2,800 workers in the company's Waterloo facility. Tyson shares are up 11.3% for the year to date while the benchmark S&P 500 index has gained 16.8% for the period.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Marvell Technology Inc. said Tuesday it has reached an agreement to acquire Innovium Inc., a provider of software for cloud and edge data centers, in an all-stock deal valued at $1.1 billion. The deal is expected to close by year-end and to add $150 million in incremental revenue in fiscal 2023. It's expected to be neutral to Marvell's adjusted per-share earnings in the first quarter after close and too boost it in the first full fiscal year after that. Marvell, which makes infrastructure semiconductor software, has a portfolio of Ethernet switch semiconductor solutions for the enterprise and carrier segment. "Innovium's TERALYNX(TM) switching architecture delivers the ultra-low latency, optimized power, high performance, and innovative telemetry that are critical in today's cloud-scale data centers," Marvell said in a statement. The deal will allow Marvell to "immediately participate in the fastest growing segment of the switch market with a cloud-optimized solution," said the statement. Marvell shares were slightly higher premarket and have gained 27% in the year to date, while the S&P 500 has gained 16.8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Under Armour Inc. shares jumped 5.4% in Tuesday premarket trading after the athletic company reported second-quarter earnings that far exceeded expectations and raised its 2021 guidance. Net income totaled $59.2 million, or 13 cents per share, after a loss of $182.9 million, or 40 cents per share, last year. Adjusted EPS of 24 cents blew past the FactSet consensus for 6 cents. Revenue of $1.352 billion was up from $707.6 million last year and ahead of the FactSet consensus for $1.218 billion. Under Armour is now guiding for revenue growth in a low-20 percentage rate compared with previous guidance for high-teens percentage rate. EPS is expected to be 14 cents to 16 cents up from previous guidance for 2 cents to 4 cents. And adjusted EPS is expected to be 50 cents to 52 cents, up from prior guidance for a range of 28 cents to 30 cents. The FactSet consensus is for revenue of $5.346 billion, implying 19.5% growth, and EPS of 35 cents. Under Armour shares have gained 23% for the year to date while the S&P 500 index is up 16.8% for the period.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
 U.S. stock indexes relinquish solid gains Monday and stocks end mostly lower as persistent concerns about the spread of the COVID-19's delta variant create an excuse for modest selling in the first trading day for equity markets in August.
|
|
